Supreme Court Grants Big Pharma Co. Immunity for Defectively Designed Drug
Today, ruling 5 to 4, the U.S. Supreme Court dramatically limited generic drug companies’ liability for manufacturing defectively designed drugs. The case is Mutual Pharmaceutical Co., Inc. v. Bartlett. In Bartlett, Public Justice filed an amici brief with the American Association for Justice. Plaintiff Karen…